Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03115151Phase 4Terminated
A Phase 4 trial of bupivacaine hydrochloride 0.75% injection, fentanyl in postoperative pain, sponsored by UT Southwestern Medical Center. Started May 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03115151.